Amicus Therapeutics Ownership | Who Owns Amicus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Amicus Therapeutics Ownership Summary

Amicus Therapeutics is owned by 103.96% institutional investors, 0.74% insiders. Vanguard group is the largest institutional shareholder, holding 9.44% of FOLD shares. Vanguard Health Care Inv is the top mutual fund, with 6.27% of its assets in Amicus Therapeutics shares.

FOLD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Amicus Therapeutics	103.96%	0.74%	-4.70%
Sector	Healthcare Stocks	46.98%	7.90%	45.12%
Industry	Biotech Stocks	44.85%	7.67%	47.48%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	28.59M	9.44%	$283.60M
Perceptive advisors	28.06M	9.26%	$278.33M
Avoro capital advisors	27.40M	9.05%	$271.81M
Blackrock	24.37M	8.05%	$241.77M
Wellington management group llp	21.11M	6.97%	$209.39M
Jpmorgan chase	14.87M	4.91%	$147.52M
Janus henderson group	13.23M	4.37%	$131.24M
William blair investment management	13.00M	4.29%	$128.99M
State street	11.02M	3.64%	$109.29M
Redmile group	10.60M	3.50%	$105.10M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Palo alto investors lp	9.03M	10.38%	$89.58M
Perceptive advisors	28.06M	6.61%	$278.33M
Redmile group	10.60M	6.35%	$105.10M
Cm management	450.00K	4.10%	$4.46M
Avoro capital advisors	27.40M	3.62%	$271.81M
Saturn v capital management	713.54K	2.67%	$7.08M
Alphacentric advisors	202.50K	1.48%	$2.01M
Novo	2.50M	1.24%	$24.80M
Healthinvest partners ab	148.21K	0.90%	$1.47M
Sectoral asset management	216.84K	0.87%	$2.15M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	2.92M	0.00%	2.92M
Wellington management group llp	21.11M	0.04%	2.30M
Millennium management	1.89M	0.01%	1.79M
Invesco	2.55M	0.01%	1.79M
Blackrock	24.37M	0.01%	1.52M

Top Sellers

Holder	Shares	% Assets	Change
Morgan stanley	4.99M	0.00%	-4.71M
Redmile group	10.60M	6.35%	-2.66M
Pictet asset management sa	4.22M	0.05%	-2.55M
Healthcare of ontario pension plan trust fund	-	-	-2.18M
Great point partners	-	-	-1.50M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	2.92M	0.00%	2.92M	$29.01M
Assenagon asset management	845.41K	0.02%	845.41K	$8.39M
Essex investment management	268.00K	0.50%	268.00K	$2.66M
Mirae asset global etfs	235.58K	0.01%	235.58K	$2.34M
Alps advisors	231.04K	0.02%	231.04K	$2.29M

Sold Out

Holder	Change
Federated hermes	-28.00
Lindbrook capital	-40.00
Innealta capital	-47.00
Geneos wealth management	-65.00
Private wealth management group	-84.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	266	1.53%	314,899,506	-0.72%	103	0.95%	141	6.01%	75	-6.25%
Mar 31, 2024	262	7.82%	317,196,449	-0.45%	104	0.89%	133	-0.75%	80	26.98%
Dec 31, 2023	243	-0.41%	318,631,655	7.59%	108	1.08%	134	3.08%	63	-
Sep 30, 2023	244	7.96%	296,152,783	-3.72%	100	0.91%	130	20.37%	63	-16.00%
Jun 30, 2023	226	-2.16%	307,582,143	3.42%	105	1.01%	108	-13.60%	75	27.12%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	18.59M	6.27%	2.31M
Vanguard Total Stock Mkt Idx Inv	9.38M	3.16%	10.28K
iShares Russell 2000 ETF	7.53M	2.52%	-16.93K
Vanguard Small Cap Index	7.42M	2.50%	-87.70K
Delaware Small Cap Core I	5.13M	1.73%	-31.80K
Janus Henderson US Opportunistic Alpha	4.58M	1.54%	-565.02K
Janus Henderson Opportunistic Alpha MA	4.58M	1.54%	4.58M
SPDR® S&P Biotech ETF	4.49M	1.51%	49.70K
Vanguard Small Cap Growth Index Inv	4.09M	1.38%	-48.30K
Vanguard Institutional Extnd Mkt Idx Tr	3.98M	1.34%	-91.21K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 06, 2024	Campbell Bradley L	President and CEO	Sell	$98.80K
Nov 01, 2024	Campbell Bradley L	President and CEO	Sell	$85.96K
Oct 01, 2024	Campbell Bradley L	President and CEO	Sell	$79.49K
Sep 03, 2024	Campbell Bradley L	President and CEO	Sell	$87.80K
Aug 01, 2024	Campbell Bradley L	President and CEO	Sell	$77.52K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	3
2024 Q3	-	4
2024 Q2	-	3
2024 Q1	-	22
2023 Q4	-	17

FOLD Ownership FAQ

Who Owns Amicus Therapeutics?

Amicus Therapeutics shareholders are primarily institutional investors at 103.96%, followed by 0.74% insiders and -4.70% retail investors. The average institutional ownership in Amicus Therapeutics's industry, Biotech Stocks , is 44.85%, which Amicus Therapeutics exceeds.

Who owns the most shares of Amicus Therapeutics?

Amicus Therapeutics’s largest shareholders are Vanguard group (28.59M shares, 9.44%), Perceptive advisors (28.06M shares, 9.26%), and Avoro capital advisors (27.4M shares, 9.05%). Together, they hold 27.75% of Amicus Therapeutics’s total shares outstanding.

Does Blackrock own Amicus Therapeutics?

Yes, BlackRock owns 8.05% of Amicus Therapeutics, totaling 24.37M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.77M$. In the last quarter, BlackRock increased its holdings by 1.52M shares, a 6.66% change.

Who is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.38% of its assets in 9.03M Amicus Therapeutics shares, valued at 89.58M$.

Who is the top mutual fund holder of Amicus Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Amicus Therapeutics shares, with 6.27% of its total shares outstanding invested in 18.59M Amicus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools